3 Reasons Growth Investors Will Love iRadimed (IRMD) Posted byZacks Equity Research November 24, 2021 Leave a comment on 3 Reasons Growth Investors Will Love iRadimed (IRMD) iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.